A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder

NCT03403790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 369

Last updated 2024-10-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of quetiapine in actual clinical settings.

Conditions

Interventions

DRUG

Quetiapine

Oral (extended-release tablet)

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Central Contact · Astellas Pharma Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2020-03-19
Completion
2020-03-19

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03403790 on ClinicalTrials.gov